Friday Frontiers in Biomedical Science
This session will highlight brain science research, and features Dr. Kathleen Rodgers and Dr. Fei Yin. The two speakers will share a 20-minute overview of their work, with an opportunity for audience engagement. Light refreshments will be provided. Prior to the presentation at 4 p.m., there will be a reception starting at 3:30 p.m.
Title: “Development of Mas Agonists for Neurodegenerative Disease”
Dr. Rodgers is the associate director of translational neuroscience at the UArizona Center for Innovation in Brain Science. Dr. Rodgers’ research investigates the effects of modifiers of the renin-angiotensin system as therapeutics for chronic disease. Dr. Rodgers has deep domain knowledge in therapeutic development that spans discovery, IND-enabling pharmacology and toxicology, clinical trial design and regulatory submissions. She has designed and conducted numerous clinical trials and holds over 50 U.S. patents with expanded coverage in major therapeutic indications.
Title: "Disrupted Lipid Metabolism as a Mechanism of Neuroinflammation and Neurodegeneration"
Dr. Yin is the assistant director of translational neuroscience at the UArizona Center for Innovation in Brain Science and assistant professor of pharmacology. Dr. Yin has deep domain expertise in neuro-metabolism and mitochondrial biology and a background in data science. Supported by the National Institute on Aging, Dr. Yin’s research focuses on the cell type-specific role of the brain bioenergetic system and their interactions with lipid metabolism, neuroinflammation and major Alzheimer’s risk factors including ApoE4 and female sex.